medline.ch Respirationstrakt Neoplasie

	Effectiveness and Safety of Trastuzumab Deruxtecan in Chinese Patients with HER2-Mutant Metastatic Non-Small Cell Lung Cancer (RERUN): Study Protocol for a Real-World, Multicenter, Prospective, Observational Study. Adv Ther Duan J, Zhuo M, Su C, Liu Y, Wang L, Yang N, Cao B, Hu M, Jin S, Li H, Li X, Pan Y, Hu J, Lu D, Tang C, Yang B, Huang Y, Jiang G, Li W, Ni S, Sheng W, Tang K, Wang J, Wang Q, Wang Z, Si S, Wang J. PMID: 42667570 [PubMed - as supplied by publisher]
	Neuro-immune crosstalk in lung cancer brain metastasis: mechanisms, therapeutic targets, and translational opportunities. Med Oncol Wei Z, Zhou J, Mo W, Zhang H. PMID: 42667533 [PubMed - indexed for MEDLINE]
	Risk-adapted first-line therapy selection in advanced EGFR-mutant NSCLC: a practical clinical algorithm integrating tumor biology and patient factors. Med Oncol Sharma A, Tan JK, Kumar H, Bharadwaj HR. PMID: 42667515 [PubMed - indexed for MEDLINE]
	Robotic-assisted bronchoscopy for lung cancer: bibliometric and visualized analysis. J Robot Surg Song S, Zhan B, Wang Y. PMID: 42667308 [PubMed - indexed for MEDLINE]
	Predictive Value of Preoperative Chest Computed Tomography-Measured Diaphragm Thickness Combined With Pulmonary Function for Postoperative Pulmonary Complications After Anatomic Lung Resection in Elderly Patients With Clinical Stage I Non-Small Cell Lung Cancer. Am Surg Wei Z, Wei D, Wu K. PMID: 42667245 [PubMed - as supplied by publisher]
	Early physiological phenotypes and survival outcomes in advanced non-small cell lung cancer: a longitudinal study of dynamic muscle loss and functional decline. Front Oncol Yan L, Wu Y, Jiang X, Yao X. PMID: 42666707 [PubMed]
	Early dynamic immune-inflammatory and nutritional recovery signature is associated with durable benefit and early progression in advanced non-small cell lung cancer receiving first-line PD-1/PD-L1 inhibitor-based therapy: a real-world retrospective cohort study. Front Med (Lausanne) Zhan T, Cao H. PMID: 42666280 [PubMed]
	Long-term oncologic outcomes after non-intubated versus intubated video-assisted thoracoscopic surgery for non-small cell lung cancer: a systematic review and meta-analysis. Front Oncol Liao YS, Deng YP, Song JL, Yu X, Li Q, Lu B, Chen GY. PMID: 42666271 [PubMed]
	Pneumonitis in Older Patients With Non-squamous Non-small Cell Lung Cancer Treated With Pembrolizumab and Pemetrexed. In Vivo Kogure Y, Hashimoto H, Daga H, Goto Y, Yamada T, Kimura T, Miura S, Yasui H, Yamamoto N, Saka H, Kondo M. PMID: 42665428 [PubMed - indexed for MEDLINE]
	CT-guided Preoperative Localization of Impalpable Pulmonary Nodules: Comparison Between Two Devices. In Vivo Barbiero G, Battistel M, Groff S, Giraudo C, Balestro E, Calabrese F, Mammana M, Dell'amore A. PMID: 42665416 [PubMed - indexed for MEDLINE]
	Association of preoperative SUVmax with histological high-grade pattern in resected clinical stage IA lung adenocarcinoma: Derivation and temporal validation. Cancer Treat Res Commun Fumimoto S, Sato K, Katsumata T, Hanaoka N. PMID: 42664753 [PubMed - as supplied by publisher]
	A GC-MS-based exhaled VOC diagnostic model for distinguishing early-stage lung cancer from controls. Talanta Wang Z, Liu T, Liu B, Zhao H, Huang J, Dong H, Wu W, Zhang G. PMID: 42664649 [PubMed - as supplied by publisher]
	Perioperative Durvalumab for Resectable Non-Small Cell Lung Cancer: Updated Outcomes From the Phase III AEGEAN Trial. J Clin Oncol Heymach JV, He J, Harpole D, Mitsudomi T, Taube JM, Gao S, Urban L, Kang JH, Orlandi FJ, Rodriguez-Cid J, Massuti B, Mateos LL, Pasello G, Chu Q, Kolb-Sielecki J, Nakata M, Galffy G, Hochmair M, Winder T, Zukov R, Garbaos G, Horio Y, Ostoros G, Tran TV, You J, Lee KY, Antonuzzo L, Akamatsu H, Biswas B, Spira A, Crawford J, Le HT, Aperghis M, Mann H, Fouad TM, Doherty GJ, Reck M. PMID: 42664473 [PubMed - as supplied by publisher]
	Decoding Malignant Lung Ground Glass Opacities: A Radiologic-Pathologic Study From Pure to Semi-Solid Lesions. Thorac Cancer Bonis A, Pagliarini G, Verzeletti V, Cecchinato S, Michielin A, Zanardo S, De Silvestro M, Lione L, Giraudo C, Faccioli E, Cannone G, Mammana M, Rebusso A, Comacchio GM, Schiavon M, Dell'Amore A. PMID: 42663505 [PubMed - indexed for MEDLINE]
	Research progress on lactate metabolism in lung cancer: Tumorigenesis, drug resistance and clinical translation (Review). Oncol Rep Zhang Y, Shang Y, Zeng H, Ning R, Zhang X, Ao D, Cai J, Ye Q. PMID: 42663294 [PubMed - indexed for MEDLINE]
	Genomic instability, postoperative recurrence and therapeutic vulnerabilities in resectable nonâ€‘small cell lung cancer (Review). Oncol Rep Wang L, Feng Y, Liu Q. PMID: 42663281 [PubMed - indexed for MEDLINE]
	Do Generic EGFR-TKIs Perform as Well as Innovators? Real-World Evidence from Gefitinib-Treated EGFR-Mutated NSCLC in Indonesia. Asian Pac J Cancer Prev Nurhayati F, Andalucia R, Thobari JA, Syahruddin E, Anggriani Y. PMID: 42663218 [PubMed - indexed for MEDLINE]
	FGFR2 fusion as the key to targeted therapy - a case report with a diagnostic turning point. Klin Onkol Pe, Drösslerová M, Van, Bocko J. PMID: 42663156 [PubMed - indexed for MEDLINE]
	Potential pitfalls in diagnostic and therapeutic decision-making in pulmonary embolism-related obstructive shock in patients with cancer: a case report. Eur Heart J Case Rep Van den Hoek T, Kayaert P, De Caluwé E, Timmermans P Jr. PMID: 42662840 [PubMed]
	Efficacy and Safety of Durvalumab and Tremelimumab in Metastatic Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Chronic Dis Transl Med Rinaldi I, Yonatan ER, Esterita T. PMID: 42662437 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 162652

Seite 1 von 8133



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung